Onconetix, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$304K
↓-57.4% -$408Kvs FY2024 (Q4)
Gross Profit
$248K
↓-62.5% -$412Kvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $304K | $712K |
| COGS | $56K | $52K |
| Gross Profit | $248K | $660K |
| R&D | $0 | $0 |
| SG&A | $2M | $3M |
| D&A | $3K | $119K |
| Other OpEx | $0 | $0 |
| Operating Income | $0 | $0 |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · ONCO · Comparing FY2025 (Q4) vs FY2024 (Q4)